Immuno-Biological Laboratories Co., Ltd (IBL)

Immuno-Biological Laboratories Co., Ltd (IBL) is rated 3 out of 5 in the category medical devices. Read and write reviews about Immuno-Biological Laboratories Co., Ltd (IBL). IBL originates from Japan who is an Antibody and ELISA manufacturer for worldwide use. The company founder and corporate President of IBL, Mr. Tsutomu Seito is one of the pioneers of Monoclonal antibody. Mr. Seito's spirit and passion, "Supplying valuable antibodies to save people fighting against diseases all over the world" are reflected our services and products as our corporate philosophy since the establishment of the company. <History of IBL> IBL is constantly improving in antibody development since the establishment in 1982. The total number of antigens used in antibody development is over 5,000 and IBL has provided more than 10,000 contract services. <IBL Brand> We have unique in-house developed products that are supplied worldwide. The total number of IBL Products is around 500 with more than 120 ELISA products and more than over 350 antibodies. <Global Supply Network> IBL products are distributed through a network of valued international distributors in more than 80 countries in the major markets as well. <Japan Quality> IBL is maintaining the ISO13485 certification since 2009. All our antibodies and ELISA products are manufactured and controlled in-house at our head office and main laboratory located in Japan. We are proud and confident in the quality of our products and services. <Main Area> * Inflammatory Disease (Cancers, Arthritis, Hepatitis etc.) * Kidney Diseases (CKD, AKI, IgA Nephropathy(IGAN), Hypertension etc.) * Aging, Neurodegenerative (Alzheimer's disease (AD) etc.) * Glucose/Lipid Metabolism (Diabetes, Hyperlipidemia, Cardiovascular Events etc. )